oral liquid bpc-157 Liposomal 1000mcg/mL 1oz bottle – BioVara BPC-157 ORAL - Beverly Hills

Target: 1,000 mcg total blend daily (~500 mcg each) by Weeks 38

Adding peptide testing would require mass spectrometry equipment and trained personnel

Experiments conducted using a polyacrylamide-based microchannel device that allows independent control of substrate stiffness and channel dimensions revealed that optimal migration of triple-negative MDA-MB-231 and SUM159 human breast cancer cells occurs at intermediate stiffness [90]

The FDA recommends that HF validation tests be conducted before major clinical trials so that the HF-validated device can be used in the clinical trials to achieve the most accurate results possible